Associations between Heat Pain Perception and Pain Severity among Patients with Chronic Pain

Pain Medicine

Volumn 11, Issue 10, 2010, Pages 1554-1563

  Hooten, W Michael ^a,b   Sandroni, Paola ^b   Mantilla, Carlos B ^a   Townsend, Cynthia O ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b Mayo Clinic   (United States)

Author keywords

Clinical pain; Heat pain; Quantitative sensory testing

Indexed keywords

MORPHINE;

ADULT; ARTICLE; CHRONIC PAIN; COOLING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEADACHE; HEAT SENSATION; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NOCICEPTION; PAIN ASSESSMENT; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REHABILITATION CENTER; SCORING SYSTEM; SENSORY ANALYSIS; SENSORY SYSTEM; TERTIARY HEALTH CARE;

EID: 77957220218     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00940.x     Document Type: Article

References (53)

1. Shy ME, Frohman EM, So YT. Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003, 60:898-904.
2. Chong PS, Cros DP. Technology literature review: Quantitative sensory testing. Muscle Nerve 2004, 29:734-47.
3. Walk D, Sehgal N, Moeller-Bertram T. Quantitative sensory testing and mapping: A review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 2009, 25:632-40.
4. Petersen KL, Rowbotham MC. Quantitative sensory testing scaled up for multicenter clinical research networks: A promising start. Pain 2006, 123:219-20.
5. Dyck PJ, Zimmerman IR, O'Brien PC. Introduction of automated systems to evaluate touch-pressure, vibration, and thermal cutaneous sensation in man. Ann Neurol 1978, 4:502-10.
6. Dyck PJ, Zimmerman IR, Johnson DM. A standard test of heat-pain responses using CASE IV. J Neurol Sci 1996, 136:54-63.
7. Dyck PJ, Litchy WJ, Lehman KA. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995, 45:1115-21.
8. Dyck PJ, Zimmerman I, Gillen DA. Cool, warm, and heat-pain detection thresholds: Testing methods and inferences about anatomic distribution of receptors. Neurology 1993, 43:1500-8.
9. Rolke R, Baron R, Maier C. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain 2006, 123:231-43.
10. Peltier A, Smith AG, Russell JW. Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve 2009, 39:529-35.
11. Wasner GL, Brock JA. Determinants of thermal pain thresholds in normal subjects. Clin Neurophysiol 2008, 119:2389-95.
12. Backonja MM, Walk D, Edwards RR. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain 2009, 25:641-7.
13. Johnston V, Jimmieson NL, Jull G, Souvlis T. Quantitative sensory measures distinguish office workers with varying levels of neck pain and disability. Pain 2008, 137:257-65.
14. Smith BW, Tooley EM, Montague EQ. Habituation and sensitization to heat and cold pain in women with fibromyalgia and healthy controls. Pain 2008, 140:420-8.
15. Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts. Nerve growth factor study group. Diabetes Care 2000, 23:510-7.
16. Kramer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 2004, 27:2386-91.
17. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985, 23:345-56.
18. Chen L, Malarick C, Seefeld L. Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 2009, 143:65-70.
19. Younger J, Barelka P, Carroll I. Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med 2008, 9:1158-63.
20. Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg 2009, 108:308-15.
21. Townsend CO, Kerkvliet JL, Bruce BK. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Pain 2008, 140:177-89.
22. Hooten WM, Townsend CO, Bruce BK. Effects of smoking status on immediate treatment outcomes of multidisciplinary pain rehabilitation. Pain Med 2009, 10:347-55.
23. Rome JD, Townsend CO, Bruce BK. Chronic noncancer pain rehabilitation with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc 2004, 79:759-68.
24. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007, 8:8-16.
25. Bruce BK, Townsend CO, Hooten WM. Chronic pain rehabilitation in chronic headache disorders. Curr Neurol Neurosci Rep 2008, 8:94-9.
26. Townsend CO, Bruce BK, Hooten WM, Rome JD. The role of mental health professionals in multidisciplinary pain rehabilitation programs. J Clin Psychol 2006, 62:1433-43.
27. Townsend CO, Sletten CD, Bruce BK. Physical and emotional functioning of adult patients with chronic abdominal pain: Comparison with patients with chronic back pain. J Pain 2005, 6:75-83.
28. Hooten WM, Townsend CO, Bruce BK, Shi Y, Warner DO. Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation. Pain Med 2009, 10:1416-25.
29. Crisostomo RA, Schmidt JE, Hooten WM. Withdrawal of analgesic medication for chronic low-back pain patients: Improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history. Am J Phys Med Rehabil 2008, 87:527-36.
30. Cunningham JL, Rome JD, Kerkvliet JL, Townsend CO. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: A prospective analysis of admission, discharge, and 6-month follow-up medication costs. Pain Med 2009, 10:787-96.
31. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL. A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 1993, 43:1508-12.
32. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995, 45:17-23.
33. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001, 24:307-10.
34. Dyck PJ, O'Brien PC, Johnson DM, Klein CJ, Dyck PJB. Quantitative sensation testing. Peripheral Neuropathy 2005, 1063-93. Dyck PJ, Thomas PK, In, eds., Philadelphia, PA, Elsevier Saunders
35. Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine 1995, 20:956-63.
36. Rudy TE, Rudy TE. Multiaxial Assessment of Multidimensional Pain Inventory: Computer Program User's Manual 1989, Pittsburgh, PA, University of Pittsburgh
37. Hooten WM, Townsend CO, Decker PA. Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med 2007, 8:624-32.
38. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 1977, 106:203-14.
39. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: A comparative analysis. Clin J Pain 1997, 13:163-70.
40. McCracken LM, Dhingra L. A short version of the Pain Anxiety Symptoms Scale (PASS-20): Preliminary development and validity. Pain Res Manag 2002, 7:45-50.
41. Sullivan M, Pivik J. The pain catastrophizing scale: Development and validation. Psychol Assess 1995, 7:524-32.
42. McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992, 30:MS253-65.
43. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-63.
44. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-83.
45. Ware J. SF-36 Health Survey Manual & Interpretation Guide 1993, Boston, MA, Health Institute, New England Medical Center
46. DuPen S, DuPen A. Opioid Conversion Calculator 2000, Poulsbo, WA, Cynergy Group
47. Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH. Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation. Pain 2003, 105:403-13.
48. Yang CC, Lee JC, Kromm BG, Ciol MA, Berger RE. Pain sensitization in male chronic pelvic pain syndrome: Why are symptoms so difficult to treat? J Urol 2003, 170:823-6.
49. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003, 105:223-30.
50. Staud R, Nagel S, Robinson ME, Price DD. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: A randomized, double-blind, placebo-controlled study. Pain 2009, 145:96-104.
51. Rukwied R, Mayer A, Kluschina O. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain 2010, 148:407-13.
52. Rolke R, Magerl W, Campbell KA. Quantitative sensory testing: A comprehensive protocol for clinical trials. Eur J Pain 2006, 10:77-88.
53. Watkins EA, Wollan PC, Melton LJ, Yawn BP. A population in pain: Report from the Olmsted County health study. Pain Med 2008, 9:166-74.